Quotes from SSDP’s official statement:
“The U.S. Food and Drug Administration (FDA) is recommending that the Drug Enforcement Administration (DEA) classify 7-hydroxymitragynine, or 7-OH, as a Schedule I controlled substance under the Controlled Substances Act (CSA). The Department of Health & Human Services sent a press release this past Tuesday, July 25, that the FDA is taking steps to restrict 7-OH products.”
“SSDP strongly opposes the proposed federal scheduling of 7-Hydroxy-Mitragynine, or 7-OH — a naturally occurring compound found in kratom.“
“This proposed scheduling reflects outdated thinking that has failed our generation before. It undermines harm reduction, ignores real-world data, and sends a dangerous message: that consumer voices and lived experiences don’t matter.“
Source: SSDP (Students for Sensible Drug Policy)
🔗 Read the full article here